Technology | Fusion Imaging Software | February 16, 2016

Clear Guide Medical Wins FDA Clearance for Scenergy Ultrasound-CT Fusion System

Clinical device provides real-time fusion for interventional procedures on existing ultrasound machines

Clear Guide Medical, Scenergy ultrasound-CT fusion system, FDA clearance

February 16, 2016 — Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its computed tomography (CT)-ultrasound fusion and image guidance system, the Clear Guide Scenergy. The device helps interventional radiologists and surgeons perform minimally invasive biopsies and other diagnostic and therapeutic procedures through an intelligently integrated display of fused ultrasound and CT images. The system is sold as an accessory to most ultrasound machines.

Working in collaboration with partner hospitals, Scenergy was developed in response to a clear need for simpler multimodality imaging using ultrasound while minimizing the number of CTs and time spent in the CT suite. By showing the clarity of CT with the real-time visualization of ultrasound, users experience the benefits of both modalities simultaneously. Procedure duration will drop with Scenergy's fully automated registration process. Best of all, Scenergy does not require special needles or new imaging equipment, preserving the customary workflow and maximizing the productivity of existing capital equipment.

Clear Guide Medical designed the device to address the myriad challenges associated with working with CT and ultrasound images simultaneously. Current fusion systems require long and complex registration processes. Scenergy eliminates this step through automated registration and system fusion, which is continuously updated throughout the procedure. The time required for registration drops to seconds. Moreover, clinical recommendations to reduce CT radiation doses heighten the importance of good ultrasound visualization. With CT precisely overlaid on the ultrasound plane, deep and challenging lesions can be visualized and targeted efficiently.

"The ability to see my target lesion clearly before, during and after a procedure means procedures can be reliably performed in ultrasound with real-time imaging, freeing up the CT suite for diagnostic imaging and mitigating exposure to ionizing radiation for the patient and staff," said Joseph Fonte, M.D., of Brigham and Women's Hospital in Boston. "This is a game-changer."

The intuitive instrument navigation overlays the path of standard instruments on the imaging. The ability to lock in a target, then realign the probe from a different angle and find that target with precision can be helpful in a number of situations.

The Scenergy is not yet available for sale outside the United States. Clear Guide Medical is currently pursuing other international clearances for clinical use. A research system was already installed in the National Institutes of Health (NIH) Center for Interventional Oncology.

For more information: www.clearguidemedical.com

Related Content

Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.
News | Ultrasound Imaging | June 12, 2019
Konica Minolta Healthcare announced a new autologous biologics workshop in partnership with EmCyte Corp. The workshop...
Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
Medivis SurgicalAR Gets FDA Clearance
Technology | Virtual and Augmented Reality | June 10, 2019
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has...
Civco Launches Envision Ultrasound Viral Barriers
Technology | Ultrasound Imaging | June 06, 2019
Civco Medical Solutions announced a new solution that removes gel from ultrasound procedures. Envision viral barriers...
SCCT Announces 2019 Gold Medal Award Recipients
News | Computed Tomography (CT) | June 05, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present the 2019 Gold Medal Award to Jonathon Leipsic, M....
Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Einstein Healthcare Network found that use of automated power injectors reduced CT contrast extravasation rates over a 30-month period.

Feature | Computed Tomography (CT) | May 30, 2019 | By Jeff Zagoudis
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S.
Sponsored Content | Webinar | Computed Tomography (CT) | May 30, 2019
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients.